(October 17 19:11) Reuters.com Business
Express Scripts Holding Co , one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc , but is excluding a rival medication made by Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers. The decision represents a setback for Teva, which is in the midst of a corporate restructuring and had hoped to capture a sizable stake
You can find the original article
here